• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌术前分期中膀胱内及膀胱周围肿瘤生长情况:经直肠超声检查和高分辨率磁共振成像的作用

Intra- and perivesical tumor growth in preoperative staging of bladder cancer: the role of transrectal ultrasonography and high resolution magnetic resonance imaging.

作者信息

Ruether U, Guhl L, Schmidt A, Stilz S, Bader H, Nunnensiek C, Rassweiler J, Eisenberger F, Jipp P

机构信息

Clinic of Internal Medicine, Department of General Internal Medicine, Institute of Pathology, Katharinenhospital, Stuttgart, FRG.

出版信息

Urol Int. 1993;50(3):141-7. doi: 10.1159/000282472.

DOI:10.1159/000282472
PMID:8465480
Abstract

Bladder tumors were staged preoperatively before and/or after M-VEC poly-chemotherapy using transrectal ultrasonography and magnetic resonance imaging in 46 patients. The resultant findings were each compared with histomorphologic results. The sensitivity of both methods compared with pathohistology was 88%. Using this technique, the degree of tumor invasion of the bladder wall could be evaluated and the appropriate therapy selected. Further applications included the monitoring of transurethral resection determine its adequacy as a treatment modality.

摘要

46例患者在M-VEC多药化疗之前和/或之后,使用经直肠超声和磁共振成像对膀胱肿瘤进行术前分期。将所得结果分别与组织形态学结果进行比较。与病理组织学相比,这两种方法的敏感性均为88%。使用该技术,可以评估膀胱壁肿瘤浸润程度并选择合适的治疗方法。进一步的应用包括监测经尿道切除术,以确定其作为一种治疗方式的充分性。

相似文献

1
Intra- and perivesical tumor growth in preoperative staging of bladder cancer: the role of transrectal ultrasonography and high resolution magnetic resonance imaging.膀胱癌术前分期中膀胱内及膀胱周围肿瘤生长情况:经直肠超声检查和高分辨率磁共振成像的作用
Urol Int. 1993;50(3):141-7. doi: 10.1159/000282472.
2
[Polychemotherapy using the M-VEC protocol (methotrexate, vinblastine, epirubicin, cisplatin) in advanced urinary bladder cancer--effectiveness and toxicity].[采用M-VEC方案(甲氨蝶呤、长春碱、表柔比星、顺铂)的多药化疗用于晚期膀胱癌——疗效与毒性]
Urologe A. 1989 Jan;28(1):25-30.
3
[The M-VEC chemotherapy of advanced bladder tumors].[晚期膀胱肿瘤的M-VEC化疗]
Khirurgiia (Sofiia). 1989;42(6):39-45.
4
Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.浸润性尿路上皮癌的辅助化疗:甲氨蝶呤、长春新碱、顺铂、环磷酰胺、阿霉素和博来霉素(MVP-CAB)方案的经验:初步报告
Jpn J Clin Oncol. 1993 Oct;23(5):291-8.
5
Histopathologic changes of transitional cell carcinoma of bladder after M-VAC chemotherapy.
Urology. 1989 Dec;34(6):357-9. doi: 10.1016/0090-4295(89)90441-x.
6
Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.甲氨蝶呤、长春碱、阿霉素和顺铂化疗对下尿路移行细胞癌淋巴结转移患者的影响。
Semin Urol. 1993 Feb;11(1):14-9.
7
[Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers].甲氨蝶呤、长春花碱、阿霉素和顺铂(M-VAC)化疗方案治疗晚期尿路上皮癌的临床与病理评估
Gan To Kagaku Ryoho. 1990 Sep;17(9):1909-15.
8
[Neoadjuvant chemotherapy with MVC (methotrexate, vinblastine, cisplatin)in the treatment of infiltrating transitional carcinoma of the bladder].
Arch Ital Urol Nefrol Androl. 1990 Jun;62(2):237-42.
9
[Adjuvant chemotherapy with biocisplatin, methotrexate and biocarbazine in advanced bladder tumors].
Khirurgiia (Sofiia). 1989;42(6):45-8.
10
[Is down-staging of advanced bladder cancer by neoadjuvant chemotherapy possible?--MVEC protocol].
Urologe A. 1992 Jul;31(4):243-6.